Key Initiatives
NCI has worked to leverage its role as the leader of the National Cancer Program to expand our understanding of cancer and to translate new knowledge into better cancer prevention and treatment. Although the majority of NCI’s funding supports investigator-initiated science, the institute also invests in major research initiatives to facilitate and support research on specific issues of importance to the cancer research enterprise. Some of these key initiatives include:
The RAS Initiative
NCI established this initiative to develop effective therapies against tumors that contain mutations in members of the RAS family of oncogenes. The RAS Initiative highlights NCI’s ability to bring together experts from across the research enterprise to address pressing scientific and clinical questions in cancer.